Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina
Authors:
- Hisao OgawaHOHisao Ogawa
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 128 (6) , 547-551
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 32 references indexed in Scilit:
- Aspirin for Primary Prevention of Cardiovascular Events in People With DiabetesCirculation, 2010
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Munc13-4 Is a GTP-Rab27-binding Protein Regulating Dense Core Granule Secretion in PlateletsJournal of Biological Chemistry, 2004
- Increased Rate of Formation of Small-Sized Platelet Aggregates in Patients With Acute Coronary SyndromesJapanese Circulation Journal, 2000
- Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser light scattering to assess platelet aggregabilityCardiovascular Research, 1998
- Factors that affect the size of platelet aggregates in epinephrine-induced activation: A study using the particle counting method based upon light scatteringThrombosis Research, 1996
- Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotoninThrombosis Research, 1996
- Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate.Circulation, 1994
- Detection of Platelet Aggregates with a Particle Counting Method Using Light ScatteringAnalytical Biochemistry, 1994
- Platelet serotonergic mechanisms in ischaemic heart diseaseThrombosis Research, 1990